Epigenomics AG / Key word(s): Strategic Company Decision/ContractEpigenomics AG: Agreement on the Acquisition of Almost All Assets 24-Jul-2023 / 18:29 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News – a service of EQS Group AG.The issuer is solely responsible for the content of […]
Author: mark
24. July 2023
Epigenomics AG Announces Successful Agreement on the Acquisition of Significant Assets
EQS-News: Epigenomics AG / Key word(s): Strategic Company Decision/ContractEpigenomics AG Announces Successful Agreement on the Acquisition of Significant Assets 24.07.2023 / 18:40 CET/CESTThe issuer is solely responsible for the content of this announcement. Epigenomics AG Announces Successful Agreement on the Acquisition of Significant Assets Acquirer is U.S. full-service diagnostics and CRO services company New Day […]
12. June 2023
Epigenomics AG: Negotiations on the Acquisitions of Almost All Assets
Epigenomics AG / Key word(s): MiscellaneousEpigenomics AG: Negotiations on the Acquisitions of Almost All Assets 12-Jun-2023 / 10:21 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News – a service of EQS Group AG.The issuer is solely responsible for the content of this announcement. […]
31. May 2023
Epigenomics AG Reports Financial Results for the First Quarter of 2023
EQS-News: Epigenomics AG / Key word(s): Quarterly / Interim Statement/Quarter ResultsEpigenomics AG Reports Financial Results for the First Quarter of 2023 31.05.2023 / 08:00 CET/CESTThe issuer is solely responsible for the content of this announcement. Epigenomics AG Reports Financial Results for the First Quarter of 2023 Berlin (Germany) and San Diego, CA (USA), May 31, […]
19. May 2023
Epigenomics AG: Changes in the Management
Epigenomics AG / Key word(s): Personnel/MiscellaneousEpigenomics AG: Changes in the Management 19-May-2023 / 17:48 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News – a service of EQS Group AG.The issuer is solely responsible for the content of this announcement. Epigenomics AG: Changes in […]
19. May 2023
Epigenomics AG: Member of the Executive Board and Chief Scientific Officer Andrew Lukowiak Resigns
EQS-News: Epigenomics AG / Key word(s): Personnel/MiscellaneousEpigenomics AG: Member of the Executive Board and Chief Scientific Officer Andrew Lukowiak Resigns 19.05.2023 / 18:00 CET/CESTThe issuer is solely responsible for the content of this announcement. Epigenomics AG: Member of the Executive Board and Chief Scientific Officer Andrew Lukowiak Resigns Berlin (Germany), May 19, 2023 -The Member […]